Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma-Reference-Cited by-同舟云学术

Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma

Published:2019-01-21 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Di Lullo Giulia,Marcatti Magda,Heltai Silvia,Tresoldi Cristina,Paganoni Anna Maria,Bordignon Claudio,Ciceri Fabio,Protti Maria Pia

Funder

Associazione Italiana per la Ricerca sul Cancro

Fondazione Umberto Veronesi

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Multiple myeloma;Palumbo;N Engl J Med.,2011

2. Bone marrow microenvironment and the identification of new targets for myeloma therapy;Podar;Leukemia,2009

3. The immune microenvironment of myeloma;Noonan;Cancer Microenviron.,2011

4. Tumor antigen-specific CD4(+) T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies;Protti;Tissue Antigens,2014

5. Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies;Guillerey;Cell Mol Life Sci.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IL-22 in cancer;Medical Oncology;2024-09-05

2. Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma;Critical Reviews in Oncology/Hematology;2023-08

3. Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies;Current Treatment Options in Oncology;2023-01-26

4. Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms;Frontiers in Immunology;2022-10-12

5. High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients;Frontiers in Oncology;2022-08-31